COVID Updates and all the latest additions to the IHIF COVID-19 Toolkit

U.S. Government Buys More Doses of Lilly Antibody Therapy
Indianapolis-based Eli Lilly and Co. (NYSE: LLY) says the U.S. government has purchased 650,000 additional doses of the company's COVID-19 antibody therapy bamlanivimab. Lilly says the government is paying more than $812 million for the doses, which will be delivered through January 31. 
Enrollment for COVID Vaccine Trial Begins in Indy
The Indiana University School of Medicine in Indianapolis has begun enrolling volunteers for a late-stage clinical study of an investigational COVID-19 vaccine from AstraZeneca plc (Nasdaq: AZN). The school was chosen in September as one of a dozen sites across the U.S. to study the vaccine candidate. IU says since the announcement, more than 3,000 Hoosiers volunteered for the study, though only about 1,000 volunteers will be selected. Read More
Another Lilly Drug Lands FDA Authorization for COVID
The U.S. Food and Drug Administration has issued another Emergency Use Authorization for a COVID-19 treatment developed by Indianapolis-based Eli Lilly and Co. (NYSE: LLY). The latest EUA allows for the distribution and emergency use of baricitinib, which was originally developed for the treatment of rheumatoid arthritis. 
IU to Lead Nationwide COVID Immunity Study
A team of researchers from the Indiana University School of Public Health and Department of Biology in Bloomington have been tapped to lead a nationwide COVID-19 study. The university says the study will examine infection and reinfection of the disease, as well as the potential for long-term immunity to the coronavirus. 
Roche partners with Moderna to include SARS-CoV-2 antibody test in ongoing COVID-19 vaccine trials
Basel, 9 December 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced a partnership with Moderna Inc. to utilise the Elecsys® Anti-SARS-CoV-2 S antibody test in Moderna’s mRNA-1273 vaccine research trials. 
With the possibility of COVID-19 vaccines becoming available soon, get the facts on vaccine development. Learn more about the scientific rigor that goes into developing a vaccine, and how the vaccine process is safe and effective.
For your vaccine storage needs: Eppendorf’s CryoCube -80C freezers, are all in stock and on a promotion that includes racks. 

  • Cryocube F570/h (400 box capacity)
  • CryoCube F740/hi (~600 box capacity)
  • Model includes free external monitoring software

Contact Nick Yonts to learn more!
Member News
Bloomington-based Cook Medical and several local not-for-profit groups are teaming to build a $15 million medical device manufacturing facility on the far-east side that will provide jobs in the poverty-stricken area. Cook will invest $7 million in the project at 38th Street and Sheridan Avenue, while Goodwill of Central & Southern Indiana hires about 100 employees for jobs expected to pay an average hourly wage of $16 plus benefits. The balance of the project’s cost will be covered through The Indianapolis Foundation and tax-credit financing. The collaborators chose the site specifically to help anchor the neighborhood and serve as a catalyst for more economic opportunities, IBJ’s Samm Quinn reports.
Jim Dillon, Former St. Jude Medical Executive, Joins FAST BioMedical Board of Directors
INDIANAPOLIS (Nov. 2, 2020) — FAST BioMedical, a privately held late clinical-stage medical technology company, today announces it has named Jim Dillon to its Board of Directors. Dillon is a former St. Jude Medical and Abiomed executive, with significant experience capitalizing and commercializing first-in-class heart failure and cardiorenal syndrome technologies.
FDA lets Toralgen's insulin-delivering nanopill into tech scheme
The FDA has accepted Toralgen’s polybile nanopill into its Emerging Technology Program. Getting into the program sets Toralgen up to meet with the FDA’s emerging technology team to resolve potential technical and regulatory issues that could slow the progress of its nanopill.
Read More (Source: Fierce Biotech)
A total of 36 therapeutic technologies are currently under development for treating diseases -- including two technologies directly linked to the fight against COVID-19.
Indy Pharmaceutical Facility Lands Incentives
A major project near Indianapolis International Airport is receiving support from the city. The Indianapolis City-County Council has unanimously approved tax abatement for Advanced Accelerator Applications USA Inc.'s planned $72 million pharmaceutical and manufacturing logistics facility. 
Welcome New IHIF Members!
Follow IHIF on Twitter to keep up with all of the latest news, events, and exclusive member benefits!

Featured New Member
Innovation drives everything we do for our customers. We improve the performance of laboratories by offering high quality fume hoods, lab casework, lab furniture and accessories while delivering best in class project execution. Our direct employees work with planners, the construction industry and owners to create a highly effective design and installation process. Tailoring the right product solution for the needs of the users enables laboratory staff and students to have a lab that works for them. Our highly adaptable solutions ensure your laboratory solves the needs for today, while allowing for quick and cost-effective adaptability to keep up with the ever-changing needs of the future.
IHIF's Policy Corner
What We're Following at Home and on the Hill

  • Find your legislators and keep up with IHIF's advocacy efforts - here
  • Policy Forum Members: Keep an eye out in January for Indiana Session Updates

IHIF Actions
  • Joined sign-on letter to HHS asking that all FDA-approved treatments for COVID, including those approved under an Emergency Use Authorization (EUA), must be covered for Medicaid beneficiaries without delay and without prior authorization (PA) requirements. 
  • Signed on to PFID letter of support to Sen. Young for the Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act.
  • Signed ASP Coalition Letter Opposing MFN Rule
The Biotechnology Innovation Organization (BIO), the California Life Sciences Association (CLSA), and BIOCOM California today filed a challenge against the Department of Health and Human Services’ (HHS) attempt, during the final days of the Trump Administration, to implement for the first time ever a “Most Favored Nation” reimbursement policy for certain drugs administered by Medicare Part B providers – drastically altering this system in ways that will harm their ability to serve America’s most vulnerable senior citizens.
Multi-Cancer Early Detection Legislation Announced for Cancer Screen Week - Dec. 7-11
For so many of us, healthcare has been on the forefront of our thoughts this year. The coronavirus pandemic forced us to adapt in so many ways. An unforeseen side effect of the pandemic was the reduction in cancer screenings, especially between March and July. While the fallout from missed and delayed screenings is not fully known, we know cancer screenings are the best way to catch cancer early – when it is easier to treat.

December 7-11, we recognize Cancer Screen Week to help raise awareness of the importance of screening. Currently, the benefits of early detection are only realized for five cancers with available screenings, which means there are no early detection screenings for the majority of cancer types – even when we’re not faced with the restrictions of social distancing.

Advances in early detection research are on the cusp of significantly improving our ability to find cancer earlier, with a simple blood draw. Multi-cancer early detection (MCED) tests have the ability to detect many cancers – before patients show symptoms.

A number of MCED tests are in development and will be available to the public in the coming years. However, even after their approval by the Food and Drug Administration, Medicare coverage for these tests - which are considered preventive care - could take up to a decade or longer if Congress doesn’t act.

Recently introduced legislation, the Multi-Cancer Early Detection Screening Coverage Act, would modernize the Medicare program to ensure Medicare beneficiaries will have timely access to MCED tests once they are FDA approved. The future of cancer screening includes innovative multi-cancer early detection testing, and this legislation removes coverage barriers for these tests that will provide significant value for both Medicare and patients.
To learn more about this legislation, click here.
Please feel free to share your support of the Multi-Cancer Early Detection Screening Coverage Act via social media and highlight #CancerScreenWeek December 7-11.
Upcoming Events
Save the Date
Tuesday, January 19, 2020
11:00 am – noon

The Indiana Health Industry Forum and Barnes & Thornburg LLP partner to present a seminar series on critical issues in the life sciences. Each month, a panel in the field of life sciences will be available to discuss the topic and answer questions concerning the major challenges and opportunities in the industry. We hope you will join us.

COVID and Cold Chain Distribution

There is no charge to attend.
The Federal Trade Commission (FTC) - Webinar on ‘Made In USA’ Label
2:00 PM-3:00 PM- December 15, 2020

  • Doing Business Under the Current Policy – What is the current policy? … and What Are the Compliance or Policy Challenges Under the Current Framework?
  • What is the Commission’s Current Approach to Addressing Deceptive Made in USA Claims?
  • Consumer Perception – How Do Consumers Interpret Made In USA Claims?
  • Are there proposed policy changes?

Cost $25

FEATURED PRESENTER:  Julia Solomon Ensor Attorney, Bureau of Consumer Protection, FTC

The U.S. Commercial Service is the lead trade promotion agency of the U.S. Government. U.S. Commercial Service trade professionals in over 100 U.S. cities and more than 75 countries help U.S. companies get started in exporting or increase sales to new global markets.
With the industry preparing for increased activity around partnering events in 2021, due in part to the virtual and hybrid nature of hosted meetings, it will be critical to establish a strategic roadmap for engagement that accelerates the effectiveness of your business development efforts. 

Elevate your presence at BIO’s established portfolio of independent investor and partnering events and attract the attention of hundreds of business development leaders, licensing professionals and investors from across the globe. 

January 11-15, 2021
Affordable access to BIO One-on-One Partnering, with an integrated video conferencing system, to provide a seamless partnering experience for all attendees, regardless of whether you are registered for a specific event during JPM week. BIO Members* partner for free/ Non-Member companies partner for $150.

February 16-18, 2021
For more than 20 years, the BIO CEO & Investor Conference has fueled biotech industry networking with premier investor and banking communities, focused on established and emerging publicly traded and select private biotech companies. For the discounted rate of $795 (20% savings), use code BIOCEO12.

With a robust landscape of BD and investors events taking place over the next six months, now is the time to develop a strategic sponsorship platform that allows you access to BIO’s global network of biopharma leaders. BIO Members* receive the greatest discounts to attend BIO events. Email us at to request your discount code or join today!

*Please note, IHIF Membership does not qualify for the BIO Member discounts.
Announcing the 2020 - 2021 IN Life Sciences Collaboration Conference Series!

Since 2006, CBLS has been presenting the Indiana Life Sciences Collaboration Conference Series, providing a forum for professionals in healthcare and life sciences to consider, discuss, and debate key business strategy issues. The conferences bring together leaders from industry, academia, government, and economic development communities. Join us in exploring business solutions and making new connections in the life sciences.
This year's series will begin virtually, building upon great subjects and quality presenters just as in previous years. The November format is modified for a half-day schedule over a two day span. We are excited to leverage the highly ranked Kelley School of Business' online learning resources for educational and networking opportunities for the series!
Advances in Behavioral/Mental Health Treatments
February 19, 2021
Lessons Learned from the Pandemic
April 30, 2021
Format TBD
Industry News
Amazon has extended its tendrils into yet another element of our daily lives: prescription medicines. The retail colossus opened an online pharmacy Tuesday that allows customers to order medication or prescription refills for home delivery. Investors in CVS Health Corp., Walgreens and Rite Aid got a sudden case of the shakes as their stocks tumbled Tuesday, and they may need long-term prescriptions for antidepressants. Analysts note that Amazon could become an attractive option for people who don’t have insurance or anyone who wants to take advantage of the online behemoth’s buying power.
BioCrossroads Report Spotlights Tech Transfer
BioCrossroads has released a report it says highlights the technology transfer efforts among Indiana's top research universities. The state's life sciences initiative says the report also reveals the increasing role of incubators and graduation facilities at research universities. 
Zimmer Biomet Launches Foundation, Partners with NAACP
Warsaw-based Zimmer Biomet Holdings Inc. (NYSE: ZBH) has launched a foundation focused on supporting STEM education and enabling community health, especially in underserved communities. The Zimmer Biomet Foundation says it will build on its corporate support of local and global healthcare communities through its “Movement is Life” initiative.
Elanco Moving Global HQ to Indy
Greenfield-based Elanco Animal Health Inc. (NYSE: ELAN) is making a major statement about its future in Indiana. The company has announced plans to relocate its global headquarters to a new 45-acre campus at the site of the former GM Stamping Plant in downtown Indianapolis as part of a $300 million investment to make Indiana its base of operations. Elanco says the massive investment will retain more than 1,600 jobs and create more than 570 jobs over the next decade.  
Read More (Inside Indiana Business)
Baxter BioPharma Solutions Announces $50 Million Investment to Expand Sterile Fill/Finish Manufacturing Site in Bloomington, Ind.
Business Wire
Baxter International Inc., a global leader in sterile medication production and delivery, today announced a $50 million expansion of its sterile fill/finish manufacturing facilities located in Bloomington, Ind. These facilities are operated by Baxter’s BioPharma Solutions business, a premier contract manufacturing organization that specializes in parenteral (injectable) pharmaceuticals. The expansion is being funded by a combination of Baxter and client investment. Additional details of the agreement were not disclosed.

The planned expansion of existing facility infrastructure includes construction of a new 25,000 square foot warehouse; a new filling line for flexible plastic containers; a high-speed automated syringe fill line capable of filling up to 600 units per minute and a new high-speed automated visual inspection line. Construction is currently underway and is expected to be completed in 2021.
BIO Business Solutions provides cost-savings offers to eligible IHIF Members. To learn more about the programs and services available, please click here. Not an IHIF member? Join today! See the latest deals and offers from our BIO Business Solutions partners here
New Business Solutions Program Partner - Research Solutions

Open to Eligible IHIF Members
15% Off: On-Demand Document Retrieval
BIO's newest partner, Research Solutions, is trusted by more than 70% of the world's top pharmaceutical companies and emerging life science businesses. Through our partnership, we're pleased to offer our members an exclusive 15% discount on its award-winning SaaS platform, Article Galaxy, for simplified and lowest-cost access to the latest scientific content.

Highlights include:
• On-demand access to 70M+ journal articles
• Full-text PDFs delivered within minutes
• Integrated search with 70+ discovery websites
• Lowest-cost filtering, including Open Access
• PDF tracking and duplicate order alerts
• 20% savings on journal article spend

Exclusive benefits for BIO/IHIF members:
• 15% off annual Article Galaxy subscription
• 14 day, risk-free trial
New from PSC Biotech
ACE Essentials Promotion
PSC has launched a limited time offer exclusively for BIO members: Now through January 31, 2021, members can receive 50% off the initialization fee of their eQMS, ACE Essentials™, which equates to savings of $9,500! 
Expanded Professional Service Offerings
PSC now offers a 10% discount on all their professional services to BIO members. This includes services such as:
·     Computer System Validation
·     Commissioning
·     Qualification and Validation
·     Regulatory Affairs
·     Audits
·     Quality Assurance
·     Quality Control
·     Engineering
·     Technical Writing
·     Calibration
·     Project Management
·     and more
Regulatory Affairs Survey
PSC Software, your compliance partner, with BIO Business Solutions ® is launching a free webinar series in January of 2021 focusing on Regulatory Affairs! PSC anticipates building a series that dives deep into regulatory topics to ensure your products make it to patients. We would appreciate your feedback and cooperation. 
Unifirst Offers Alternative Solutions for Workwear Needs

Featured Program
About Nikon Instruments, Inc.
Nikon is a world-renowned brand, firmly established as a market leader in optics instrumentation and the only microscope company to manufacture its own glass, ensuring the very finest quality assurance throughout production. Nikon’s broad portfolio of microscope systems includes products for the educational, clinical, materials science, and research market as well as the biotech/pharma industry.
IHIF Member Benefits 

  • 15% off select customized microscope packages, 7% off individual Nikon items, and 5% off 3rd party products
  • Free installation, unless specified on quote
  • 1 Year Warranty Full on Systems, 5 Year Warranty on Microscopes, and 15% off a wide variety of Warranty Extension Programs
  • Free on-site customized training
  • Highly trained Nikon teams throughout the Americas partner with customers to build unique systems solutions
  • Fully integrated flexible customized packages for expediting discovery to commercialization - easily scaled up for larger operations
  • Seamless integration of third party products
  • One unified software solution
About IHIF Membership

Now is a great time to become a member of the Indiana Health Industry Forum! Join your voice to over 150 current member companies to impact the strategic direction of Indiana's health science sector.

Membership in IHIF offers a number of solutions:
  • Promote your business, locally, nationally, and globally.
  • Support the industry in the state and contribute directly to its growth and direction.
  • Find others who share your interests and build your business network.
  • Lend your voice to public policies that support innovation.
  • Directly impact your bottom line with significant savings and discount programs exclusively for IHIF members.

To complete a membership application, click here. 
Time to renew? Try it on-line! It's quick and easy! IHIF members can renew their memberships on-line at any time and update information in the Member Directory. Not an IHIF Member? Apply on-line or download an application packet now!